Medacta Group Ausschüttungen und Rückkäufe
Zukünftiges Wachstum Kriterienprüfungen 0/6
Medacta Group ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.47%.
Wichtige Informationen
0.5%
Dividendenausschüttung
0.2%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 0.6% |
| Zukünftige Dividendenrendite | 0.9% |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | CHF 0.550 |
| Ausschüttungsquote | 21% |
Jüngste Updates zu Dividenden und Rückkäufen
Recent updates
The Price Is Right For Medacta Group SA (VTX:MOVE)
Nov 22
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: MOVE zahlt keine nennenswerte Dividende für den Markt Swiss, daher muss nicht geprüft werden, ob die Zahlungen stabil sind.
Wachsende Dividende: MOVE zahlt keine nennenswerte Dividende für den Markt Swiss, daher ist es nicht notwendig zu prüfen, ob die Zahlungen steigen.
Dividendenrendite im Vergleich zum Markt
| Medacta Group Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (MOVE) | 0.5% |
| Untere 25 % des Marktes (CH) | 2.0% |
| Markt Top 25 % (CH) | 4.4% |
| Branchendurchschnitt (Medical Equipment) | 0.7% |
| Analystenprognose (MOVE) (bis zu 3 Jahre) | 0.9% |
Bemerkenswerte Dividende: MOVEDie Dividende des Unternehmens (0.47%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt Swiss (2.04%) nicht bemerkenswert.
Hohe Dividende: MOVEDie Dividende des Unternehmens (0.47%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Swiss (4.43%) niedrig.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: MOVE zahlt keine nennenswerte Dividende für den Markt Swiss.
Barausschüttung an die Aktionäre
Cashflow-Deckung: MOVE zahlt eine Dividende, aber das Unternehmen hat keinen freien Cashflow.